StonvexLoading…
StonvexStonvexStonvexCore line items from NN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.57M | $5.67M | $3.86M | $3.93M |
Operating Income | $-70.23M | $-60.10M | $-63.53M | $-65.54M |
Net Income | $-189.25M | $-101.88M | $-71.73M | $-40.12M |
EPS (Diluted) | $-1.42 | $-0.84 | $-0.66 | $-0.40 |
Total Assets | $247.02M | $161.74M | $162.16M | $123.79M |
Total Liabilities | $333.25M | $111.62M | $82.06M | $19.92M |
Cash & Equivalents | $44.76M | $39.33M | $81.88M | $47.23M |
Free Cash Flow OCF − CapEx | $-50.80M | $-38.36M | $-38.19M | $-40.06M |
Shares Outstanding | 135.37M | 131.14M | 111.13M | 106.42M |